| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/20/1989 | EP0332952A2 Polysulfated heparin combinations against retrovirus infections |
| 09/20/1989 | EP0332879A2 Monoclonal antibody recognizing un-natural ganglioside GD3 |
| 09/20/1989 | EP0332865A2 Suppression of B-cells in mammals |
| 09/20/1989 | EP0332677A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same |
| 09/20/1989 | EP0332659A1 Immunogenic glycopeptides of human cytomegalovirus |
| 09/20/1989 | CN1035679A Nanbv diagnostics and vaccines |
| 09/19/1989 | US4868118 Cloning and expression of the 47-kilodalton antigen of treponema pallidum |
| 09/19/1989 | US4867975 Cold-adapted virus mutant |
| 09/19/1989 | US4867962 Anticancer, mixtures of binding patterns to increase amount at target site |
| 09/19/1989 | CA1259566A1 Vaccines and compositions against hepatitis b viral infections |
| 09/13/1989 | EP0332323A1 Carrier for affinity chromatography immobilized with antibodies and preparation thereof |
| 09/13/1989 | EP0332241A2 Live combination vaccine |
| 09/13/1989 | EP0332225A2 Antibody to polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
| 09/13/1989 | EP0332022A2 Magnetic protein conjugates, process for their production and their use |
| 09/12/1989 | US4866041 Synthesis of tumor antigenic determinant |
| 09/12/1989 | CA1259450A1 Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
| 09/08/1989 | WO1989008255A1 Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses |
| 09/08/1989 | WO1989008130A1 Immobilized artificial membranes |
| 09/08/1989 | WO1989008118A1 Synthetic scm-active cancer recognition peptides |
| 09/08/1989 | WO1989007948A1 Antihypertensive hyperimmune milk, production, composition, and use |
| 09/08/1989 | WO1989007947A1 Improvements relating to antigens |
| 09/08/1989 | WO1989007946A1 Virally modified tumour vaccines for immunotherapy of tumour metastases |
| 09/07/1989 | DE3904303A1 Structural phosphoprotein (pp28) of human cytomegalovirus (HCMV), its preparation and use |
| 09/06/1989 | EP0331439A2 Monoclonal antibodies recognizing atrial natriuretic polypeptide, their preparation and use |
| 09/06/1989 | EP0331186A2 Monoclonal antibody selectively binding to novel g-csf derivative |
| 09/06/1989 | EP0331102A1 Virus-modified tumour vaccine for the immunotherapy of tumour metastases |
| 09/06/1989 | EP0331034A2 Functionally specific antibodies |
| 09/06/1989 | EP0330781A1 Vaccine against rinderpest virus using recombinant vaccinia virus |
| 09/06/1989 | EP0330696A1 Recombinant antibodies and methods for their production |
| 09/06/1989 | EP0330681A1 Vaccines against animal parasitic nematodes |
| 09/05/1989 | US4864020 Monoclonal antibodies and cell lines for parathyroid tissue-specific antigen parathyroid-specific |
| 09/05/1989 | US4863857 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known |
| 09/05/1989 | US4863854 Monoclonal antibodies to mucin-like human differentiation antigens |
| 09/05/1989 | US4863853 Carcino-embrionic antigen |
| 09/05/1989 | US4863735 Biodegradable polymeric drug delivery system with adjuvant activity |
| 09/05/1989 | US4863731 Method and compositions for the control of coccidiosis in poultry |
| 09/05/1989 | US4863730 Antibodies |
| 09/05/1989 | US4863726 Combination therapy using immunotoxins with interleukin-2 |
| 09/05/1989 | US4863609 Process for the fractional separation of protein mixtures by means of membranes |
| 09/05/1989 | CA1259045A1 Membrane polysaccharides useful as drugs and preparation process thereof |
| 09/05/1989 | CA1259029A1 Fluorometric assay of 1gg.sub.4 and reagents therefor |
| 08/30/1989 | EP0330647A2 The use of chymotrypsin for the inactivation of prekallikrein activator |
| 08/30/1989 | EP0330521A2 Antihypertensive hyperimmune milk |
| 08/30/1989 | EP0330506A2 VLA proteins |
| 08/30/1989 | EP0330359A2 Composition useful in the diagnosis and treating of HIV-1 infection |
| 08/30/1989 | EP0330201A2 Method of enhancing the effect of cytotoxic agents |
| 08/30/1989 | EP0330080A2 Method and means for the determination of kidney damage |
| 08/30/1989 | EP0330051A1 Human cytomegalovirus structural phosphoprotein (pp28), its preparation and use |
| 08/30/1989 | EP0329761A1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
| 08/30/1989 | EP0329760A1 Suppressive t lymphocyte cell lines and supernatant derivative thereof |
| 08/30/1989 | EP0329755A1 Recombinant antibody and method |
| 08/30/1989 | EP0329737A1 Tri-aza macrocycles and metal complexes thereof |
| 08/30/1989 | CN1035128A Monoclonal antibodies, a method for the preparation thereof and use thereof |
| 08/30/1989 | CN1035126A Gene fragment coding for rabies virus glycoprotein and process for preparing rabies virus glycoprotein using the same |
| 08/29/1989 | US4861869 Coupling agents for joining radionuclide metal ions with biologically useful proteins |
| 08/29/1989 | US4861864 Rotavirus antigens |
| 08/29/1989 | US4861720 Oncornavirus vaccines and feline alpha-type interferon |
| 08/29/1989 | US4861711 Sheet-like diagnostic device |
| 08/29/1989 | US4861707 Polypeptides; aids |
| 08/29/1989 | US4861706 Newcastle virus |
| 08/29/1989 | US4861588 Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 08/29/1989 | US4861581 Detection of necrotic malignant tissue and associated therapy |
| 08/29/1989 | US4861579 Suppression of B-lymphocytes in mammals by administration of anti-B-lymphocyte antibodies |
| 08/24/1989 | WO1989007764A1 Method for detecting antibodies specific for rheumatic diseases, in particular chronic polyarthritis, and reagent therefor |
| 08/24/1989 | WO1989007650A1 Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated response and method of producing the same |
| 08/24/1989 | WO1989007645A1 Rhoptry membrane antigen of plasmodium falciparum |
| 08/24/1989 | WO1989007644A1 Pox virus vectors |
| 08/24/1989 | WO1989007618A1 Affinity matrices of modified polysaccharide supports |
| 08/24/1989 | WO1989007616A1 Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein |
| 08/24/1989 | WO1989007615A1 Immunogenic glycoproteins of human cytomegalovirus |
| 08/24/1989 | WO1989007613A1 Proteins which induce immunological effector cell activation and chemattraction |
| 08/24/1989 | WO1989007601A1 Antigens against autoimmune diseases |
| 08/24/1989 | WO1989007452A1 Improvements in or relating to antibodies |
| 08/24/1989 | WO1989007448A1 Use of synthetic peptides to generate and manipulate cellular immunity |
| 08/24/1989 | WO1989006974A3 T-cell epitope as carriers molecule for conjugate vaccines |
| 08/23/1989 | EP0329264A2 Veterinary vaccines |
| 08/23/1989 | EP0329257A2 Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum |
| 08/23/1989 | EP0329185A2 Alteration of pharmacokinetics of proteins by charge modification |
| 08/23/1989 | EP0329184A2 Antimers and antimeric conjugation |
| 08/23/1989 | EP0328589A1 Tetra-aza macrocycles and metal complexes thereof |
| 08/23/1989 | EP0328578A1 Antigen recognized by mca 16-88 |
| 08/22/1989 | US4859769 Antiviral agents |
| 08/22/1989 | US4859766 Purified appetite-regulating substances of biological orgin, their antibodies, immunocomplexes of the appetite--regulating substances formed with the antibodies and processes for preparing same |
| 08/22/1989 | US4859765 Synthetic peptide sequences useful in biological and pharmaceutical applications and methods of manufacture |
| 08/22/1989 | US4859595 Method for preparing rabbit monoclonal antibodies, the cell lines used therein and the antibodies produced thereby |
| 08/22/1989 | US4859587 Recombinant herpes simplex viruses, vaccines and methods |
| 08/22/1989 | US4859465 Vaccine capable of eliciting multivalent antibodies |
| 08/22/1989 | US4859464 Method for the purification of parasite antigenic factors |
| 08/22/1989 | US4859449 Modified antibodies for enhanced hepatocyte clearance |
| 08/22/1989 | CA1258627A1 Liposome compatible surfactants |
| 08/16/1989 | EP0328446A1 Conjugates of vinca derivatives containing a detergent chain in position C-3 |
| 08/16/1989 | EP0328404A1 Modified antibodies |
| 08/16/1989 | EP0328403A2 Synthetic peptides related to the HIV-GP120-env-protein, and their use |
| 08/16/1989 | EP0328390A2 Peptide treatment of refractory infectious diseases |
| 08/16/1989 | EP0328253A2 DNA sequences coding for avian coccidiosis antigens which induce a cell-mediated response, methods for their production, and vaccines containing them |
| 08/16/1989 | EP0328248A2 Monoclonal antibodies against a follicle-stimulating hormone |
| 08/16/1989 | EP0328147A2 Anthracycline immunoconjugates having a novel linker and methods for their production |
| 08/16/1989 | EP0328123A1 Heterogeneous, pre-S rich hepatitis B surface antigen |
| 08/16/1989 | EP0327801A1 HIV-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions |
| 08/16/1989 | EP0327648A1 Human monoclonal antibody and drug for prophylaxis and treatment of infectious diseases comprising same as effective ingredient |